Discovery of an inhibitor of DNA-driven inflammation that preferentially targets the AIM2 inflammasome

Related articles

1. ZNFX1 is a Novel Master Regulator in Epigenetically-induced Pathogen Mimicry and Inflammasome Signaling in Cancer

   This article has 31 authors:

   1. Lora Stojanovic
   2. Rachel Abbotts
   3. Kaushlendra Tripathi
   4. Collin M. Coon
   5. Saranya Rajendran
   6. Elnaz Abbasi Farid
   7. Galen Hostetter
   8. Joseph W. Guarnieri
   9. Douglas C. Wallace
   10. Sheng Liu
   11. Jun Wan
   12. Gennaro Calendo
   13. Rebecca Marker
   14. Zahra Gohari
   15. Mohammed M. A. Inayatullah
   16. Vijay K. Tiwari
   17. Tanjina Kader
   18. Sandro Santagata
   19. Ronny Drapkin
   20. Stefan Kommoss
   21. Jacobus Pfisterer
   22. Gottfried E Konecny
   23. Ryan Coopergard
   24. Jean-Pierre Issa
   25. Boris J. N. Winterhoff
   26. Michael J. Topper
   27. George E. Sandusky
   28. Kathy D. Miller
   29. Stephen B. Baylin
   30. Kenneth P. Nephew
   31. Feyruz V. Rassool

2. Inflammation cellular platform (INCEPLAT) for testing anti-inflammatory compounds for SARS-CoV-2

   This article has 12 authors:

   1. Blanca D. López-Ayllón
   2. Laura Mendoza-García
   3. Ana de Lucas-Rius
   4. Tránsito García-García
   5. Raúl Fernández-Rodríguez
   6. Antonio Romero-Guillén
   7. Judit Serrat
   8. Sonia Zúñiga
   9. Natalia Redondo
   10. Mar Siles-Lucas
   11. Juan J. Garrido
   12. María Montoya

3. Molecular basis of autoimmune disease protection by MDA5 variants

   This article has 7 authors:

   1. Rahul Singh
   2. Alba Herrero del Valle
   3. Joe D Joiner
   4. Marleen Zwaagstra
   5. Brian J Ferguson
   6. Frank J.M. van Kuppeveld
   7. Yorgo Modis